Andreas Bovopoulos filed Amendment No. 7 to Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of common stock in Cosmos Health Inc. (NASDAQ:COSM).

Key Highlights

  • Reporting person: Andreas Bovopoulos, identified as an individual investor residing in Los Gatos, California.
  • Shares beneficially owned: 8,120,988.05 shares of Cosmos Health Inc. common stock.
  • Percentage of class: Approximately 8.07%, based on 100,633,773 shares outstanding as reported by Cosmos Health Inc. in its quarterly filing for the period ended June 30, 2026.
  • Voting and dispositive power: Bovopoulos holds sole voting power and sole dispositive power over all 8,120,988.05 shares, with no shared voting or dispositive power reported.
  • Amendment number: This filing is Amendment No. 7, indicating a series of prior ownership disclosures by the same reporting person.
  • Certification: Bovopoulos certified that the shares "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

Bovopoulos Ownership Position in Cosmos Health Detailed in Schedule 13G Amendment

According to the filing, Andreas Bovopoulos, a U.S. citizen listed as an individual investor, holds 8,120,988.05 shares of common stock in Cosmos Health Inc., a company whose principal executive offices are located at 5 Agiou Georgiou, Pilea, Thessaloniki, Greece. The filing identifies Cosmos Health Inc. as the issuer, with the common stock carrying CUSIP number 221413206, and lists the company's shares on NASDAQ under the symbol COSM.

The ownership percentage of 8.07% was calculated against a total of 100,633,773 shares outstanding, a figure the filing attributes to Cosmos Health Inc.'s Form 10-Q for the quarterly period ended June 30, 2026. The filing reports zero shared voting power and zero shared dispositive power, meaning Bovopoulos acts solely and independently with respect to all reported shares. No group membership, subsidiary involvement, or ownership on behalf of another person was indicated.

This Schedule 13G amendment is designated as Amendment No. 7, reflecting that Bovopoulos has filed multiple prior updates on this position. The filing was signed by Bovopoulos on November 12, 2026, the same date identified as the event triggering the submission. The reporting person did not check any institutional category boxes under Item 3, consistent with his self-identification as an individual investor.

What Was Disclosed

Andreas Bovopoulos disclosed beneficial ownership of 8,120,988.05 shares of Cosmos Health Inc. common stock, representing approximately 8.07% of the class, with sole voting and dispositive power over all reported shares, as of November 12, 2026.